KORU Medical Systems, Inc. (KRMD)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$3.25+0.93%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · KRMD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2015 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||
| Revenues | 45.1 | 41.1 | 33.6 | 28.5 | 27.9 | 23.5 | 24.2 | 23.2 | 17.4 | 12.3 | 12.2 | 8.7 | 7.8 | 6.4 |
| Total Revenues | 45.1 | 41.1 | 33.6 | 28.5 | 27.9 | 23.5 | 24.2 | 23.2 | — | 12.3 | 12.2 | 8.7 | 7.8 | 6.4 |
| Cost of Revenues | 16.9 | 15.5 | 12.3 | 11.8 | 12.5 | 9.7 | 9.2 | 8.3 | 6.5 | — | — | — | — | — |
| Gross Profit | 28.2 | 25.6 | 21.3 | 16.7 | 15.4 | 13.8 | 14.9 | 14.9 | 10.8 | 7.6 | 7.6 | — | — | — |
| Operating Expenses & Income | ||||||||||||||
| Selling, General & Admin | 24.6 | 23.4 | 21.6 | 20.4 | 20.6 | 17.9 | 12.0 | 9.8 | 8.2 | 7.8 | 5.9 | 3.9 | 3.5 | 2.7 |
| R&D Expenses | 4.5 | 4.4 | 5.3 | 5.7 | 5.0 | 2.5 | 1.3 | 0.7 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 |
| Operating Income | (1.7) | (3.0) | (6.4) | (10.3) | (10.8) | (7.0) | (1.3) | 0.6 | 1.2 | (0.7) | 1.2 | 1.0 | 1.1 | 1.3 |
| Earnings from Continuing Operations | ||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other Non-Operating Income / Expenses | (0.2) | 0.4 | 0.4 | 0.5 | 0.1 | 0.7 | 0.1 | — | — | — | — | 0.0 | (0.0) | (0.0) |
| EBT, Incl. Unusual Items | (1.8) | (2.6) | (6.1) | (9.8) | (10.7) | (6.4) | 1.2 | 0.7 | 1.2 | (0.8) | 1.1 | 1.0 | 1.0 | 1.3 |
| Income Tax Expense | — | 0.0 | 0.0 | 4.0 | (2.0) | (1.8) | (0.0) | 0.1 | 0.3 | (0.2) | 0.4 | 0.3 | 0.3 | 0.5 |
| Net Income | ||||||||||||||
| Net Income | (1.8) | (2.6) | (6.1) | (13.7) | (8.7) | (4.6) | (1.2) | 0.6 | 0.9 | (0.5) | 0.8 | 0.7 | 0.7 | 0.8 |
| Per Share | ||||||||||||||
| Basic EPS | (0.04) | (0.06) | (0.13) | (0.30) | (0.19) | (0.10) | (0.03) | 0.01 | 0.02 | (0.01) | 0.02 | 0.02 | 0.02 | 0.02 |
| Diluted EPS | (0.04) | (0.06) | (0.13) | (0.30) | (0.19) | (0.10) | (0.03) | 0.01 | 0.02 | (0.01) | 0.02 | 0.02 | 0.02 | 0.02 |
| Revenue per Share | 0.91 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 46.1 | 46.2 | 45.8 | 45.6 | 45.0 | 44.4 | 41.9 | 38.8 | 38.1 | 37.8 | 38.0 | 36.7 | 36.0 | 34.3 |
| Diluted Weighted Avg Shares | 49.5 | 46.2 | 45.8 | 45.6 | 45.0 | 44.4 | 41.9 | 39.1 | 38.9 | 37.9 | 38.0 | 36.7 | 36.0 | 35.1 |
| Supplemental | ||||||||||||||
| EBITDA | — | (2.2) | (5.6) | (9.4) | (10.2) | (6.6) | (0.8) | 0.9 | 1.5 | (0.4) | 1.5 | 1.2 | 1.3 | 1.4 |
| EBIT | (1.7) | (3.0) | (6.4) | (10.3) | (10.8) | (7.0) | (1.3) | 0.6 | 1.2 | (0.7) | 1.2 | 1.0 | 1.1 | 1.3 |
| Effective Tax Rate | — | — | — | -40.6% | 18.9% | 28.3% | -1.5% | 19.0% | 22.6% | 31.1% | 31.5% | 30.4% | 30.1% | 36.3% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.